|
1 Indications And Usage Carbidopa, Levodopa And Entacapone Tablets, A Combination Drug Consisting Of Levodopa, Carbidopa (dopa Decarboxylase Inhibitor), And Entacapone (catechol-O-Methyltransferase-Comt Inhibitor) Is Indicated For The Treatment Of Parkinson’s Disease. Carbidopa, Levodopa And Entacapone Tablets Can Be Used: To Substitute (with Equivalent Strengths Of Each Of The Three Components) Carbidopa/levodopa And Entacapone Previously Administered As Individual Products. To Replace Carbidopa/levodopa Therapy (without Entacapone) When Patients Experience The Signs And Symptoms Of End-Of-Dose “wearing-Off” And When They Have Been Taking A Total Daily Dose Of Levodopa Of 600 Mg Or Less And Have Not Been Experiencing Dyskinesias. Carbidopa, Levodopa And Entacapone Tablets, A Combination Drug Consisting Of Levodopa (aromatic Amino Acid), Carbidopa (aromatic Amino Acid Decarboxylation Inhibitor), And Entacapone (catechol-O-Methyltransferase (comt) Inhibitor) Is Indicated For The Treatment Of Parkinson’s Disease. Carbidopa, Levodopa And Entacapone Tablets Are To Be Used: To Substitute (with Equivalent Strengths Of Each Of The Three Components) For Carbidopa/levodopa And Entacapone Previously Administered As Individual Products ( 1 ) To Replace Carbidopa/levodopa Therapy (without Entacapone) When Patients Experience The Signs And Symptoms Of End-Of-Dose “wearing-Off” And When They Have Been Taking A Total Daily Dose Of Levodopa Of 600 Mg Or Less And Have Not Been Experiencing Dyskinesias ( 1 )
|